NCT05714787

Brief Summary

It is well known that some chronic respiratory pathologies such as asthma or chronic obstructive pulmonary disease (COPD) are associated with an increased risk of osteoporosis, due to the pathology itself and the therapies implemented (per-os or inhaled corticosteroids). Osteoporosis leads to an increased risk of fragility fracture, with an increased morbidity and mortality associated with severe fractures such as vertebral fractures. Also, osteoporotic vertebral fractures often occur at the thoracolumbar hinge, resulting in worsening of the thoracic kyphosis. However, to the best of our knowledge, the prevalence of osteoporotic vertebral fractures measured by CT scan in patients with interstitial lung disease (ILD) is not known. For these patients who already have impaired respiratory function, the appearance of vertebral fractures could impact their management and worsen their prognosis (additional restrictive syndrome, difficulties in analgesics management because of respiratory contraindications, difficulties in wearing a corset, etc...). In this context, it appears interesting to define the prevalence of osteoporosis and osteoporotic vertebral fractures at the thoracic spine and the thoraco-lumbar hinge in a population of patients followed for ILD. So, the main objective of this study is to describe the prevalence of vertebral osteoporotic fractures in an overall cohort of patients with ILD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2017

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 6, 2023

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

5.9 years

First QC Date

January 20, 2023

Last Update Submit

March 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence or absence of vertebral fracture in the global cohort

    a vertebral fracture is considered if a decrease in height of the vertebral plateau by more than 20 % on an examination of chest CT scan on sagittal section after multiplanar reconstruction is observed.

    6 years

Secondary Outcomes (2)

  • Presence or absence of vertebral fracture in subgroups

    6 years

  • To compare bone mineral density in Hounsfield Unit of patients with or without at least one vertebral fracture.

    6 years

Interventions

Double examination of chest CT scan on sagittal section after multiplanar reconstruction

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients are from a cohort data base named COLIBRI which collected date about with intersititial lung disease, recruited in Pneumology Department in Centre hospitalier universitaire de Nice.

You may qualify if:

  • Patients older than 18 years old ;
  • Patients included in the COLIBRI database for ILD between January 2017 and January 2023 ;
  • Patients with a chest CT scan performed at the Nice center university hospital.

You may not qualify if:

  • Absence of a thoracic CT scan performed at Nice center university hospital
  • Secondary vertebral fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Nice

Nice, 06000, France

Location

MeSH Terms

Conditions

OsteoporosisLung Diseases, InterstitialSpinal Fractures

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesLung DiseasesRespiratory Tract DiseasesSpinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2023

First Posted

February 6, 2023

Study Start

January 23, 2017

Primary Completion

January 1, 2023

Study Completion

January 1, 2023

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

not scheduled

Locations